Post Categories Uncategorized Post dateApril 27, 2025Post last updated dateUpdated April 27, 2025 CHMFL-ABL-039, a Selective Type II Native and Drug-Resistant Mutant BCR-ABL Inhibitor for Chronic Myeloid Leukemia Post author Sodium channelPost read time1 min read Chronic myeloid leukemia (CML) is a white blood cell disorder, accounting for about 15% of...